The effect of anisotropic collagen-GAG scaffolds and growth factor supplementation on tendon cell recruitment, alignment, and metabolic activity
Source abstract
Abstract
Current surgical and tissue engineering approaches for treating tendon injuries have shown limited success, suggesting the need for new biomaterial strategies. Here we describe the development of an anisotropic collagen-glycosaminoglycan (CG) scaffold and use of growth factor supplementation strategies to create a 3D platform for tendon tissue engineering. We fabricated cylindrical CG scaffolds with aligned tracks of ellipsoidal pores that mimic the native physiology of tendon by incorporating a directional solidification step into a conventional lyophilization strategy. By modifying the freezing temperature, we created a homologous series of aligned CG scaffolds with constant relative density and degree of anisotropy but a range of pore sizes (55-243 μm). Equine tendon cells showed greater levels of attachment, metabolic activity, and alignment as well as less cell-mediated scaffold contraction, when cultured in anisotropic scaffolds compared to an isotropic CG scaffold control. The anisotropic CG scaffolds also provided critical contact guidance cues for cell alignment. While tendon cells were randomly oriented in the isotropic control scaffold and the transverse (unaligned) plane of the anisotropic scaffolds, significant cell alignment was observed in the direction of the contact guidance cues in the longitudinal plane of the anisotropic scaffolds. Scaffold pore size was found to significantly influence tendon cell viability, proliferation, penetration into the scaffold, and metabolic activity in a manner predicted by cellular solids arguments. Finally, the addition of the growth factors PDGF-BB and IGF-1 to aligned CG scaffolds was found to enhance tendon cell motility, viability, and metabolic activity in dose-dependent manners. This work suggests a composite strategy for developing bioactive, 3D material systems for tendon tissue engineering.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Tendon Structure and Treatment · Laser Applications in Dentistry and Medicine · Shoulder Injury and Treatment
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (57)
Show source-provided references
1. Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin10.1073/pnas.86.3.933 ↗
2. Optimal degradation rate for collagen chambers used for regeneration of peripheral nerves over long gaps10.1159/000075035 ↗
3. Yannas · 2001
4. Microarchitecture of three-dimensional scaffolds influences cell migration behavior via junction interactions10.1529/biophysj.107.122598 ↗
5. A new technique for calculating individual dermal fibroblast contractile forces generated within collagen-GAG scaffolds10.1529/biophysj.106.095471 ↗
6. In vivo and in vitro applications of collagen-GAG scaffolds10.1016/j.cej.2007.09.009 ↗
7. Design of a multiphase osteochondral scaffold III: fabrication of layered scaffolds with continuous interfaces10.1002/jbm.a.32387 ↗
8. Design of a multiphase osteochondral scaffold. II. Fabrication of a mineralized collagen-glycosaminoglycan scaffold10.1002/jbm.a.32361 ↗
9. Tendon: Biology, biomechanics, repair, growth factors, and evolving treatment options10.1016/j.jhsa.2007.09.007 ↗
10. Tendon tissue engineering using scaffold enhancing strategies10.1016/j.tibtech.2008.01.003 ↗
11. Functional tissue engineering for tendon repair: a multidisciplinary strategy using mesenchymal stem cells, bioscaffolds, and mechanical stimulation10.1002/jor.20456 ↗
12. The basic science of tendinopathy10.1007/s11999-008-0286-4 ↗
13. Ontogenetic transition in fetal wound transforming growth factor-beta regulation correlates with collagen organization10.1016/S0002-9440(10)63601-2 ↗
14. Cost comparison of anterior cruciate ligament reconstruction: autograft versus allograft10.1016/j.arthro.2005.04.102 ↗
15. In vivo and in vitro applications of collagen-GAG scaffolds10.1016/j.cej.2007.09.009 ↗
16. Nanofiber scaffolds with gradations in mineral content for mimicking the tendon-to-bone insertion site10.1021/nl901582f ↗
17. Novel nanofiber-based scaffold for rotator cuff repair and Augmentation10.1089/ten.tea.2008.0014 ↗
18. Anterior cruciate ligament regeneration using braided biodegradable scaffolds: in vitro optimization studies10.1016/j.biomaterials.2004.11.050 ↗
19. The role of aligned polymer fiber-based constructs in the bridging of long peripheral nerve gaps10.1016/j.biomaterials.2008.03.042 ↗
20. Accordion-like honeycombs for tissue engineering of cardiac anisotropy10.1038/nmat2316 ↗
21. Aligned-to-random" nanofiber scaffolds for mimicking the structure of the tendon-to-bone insertion site10.1039/c0nr00192a ↗
22. The regulation of tendon stem cell differentiation by the alignment of nanofibers10.1016/j.biomaterials.2009.11.083 ↗
23. Gibson · 1997
24. The effect of pore size on permeability and cell attachment in collagen scaffolds for tissue engineering10.3233/THC-2007-15102 ↗
25. The effect of pore size on cell adhesion in collagen-GAG scaffolds10.1016/j.biomaterials.2004.02.052 ↗
26. The regulation of phenotype of cultured tenocytes by microgrooved surface structure10.1016/j.biomaterials.2010.05.058 ↗
27. Microtopographically patterned surfaces promote the alignment of tenocytes and extracellular collagen10.1016/j.actbio.2009.12.047 ↗
28. The roles of growth factors in tendon and ligament healing10.2165/00007256-200333050-00004 ↗
29. Effect of several growth factors on canine flexor tendon fibroblast proliferation and collagen synthesis in vitro10.1016/j.jhsa.2004.12.006 ↗
30. Tissue engineering of flexor tendons: optimization of tenocyte proliferation using growth factor supplementation10.1089/ten.2006.12.1937 ↗
31. Dose-related cellular effects of platelet-derived growth factor-BB differ in various types of rabbit tendons in vitro10.1080/00016470152846646 ↗
32. Recombinant human insulin-like growth factor-I stimulates in vitro matrix synthesis and cell proliferation in rabbit flexor tendon10.1002/jor.1100090405 ↗
33. Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cells10.1016/j.bbrc.2007.03.049 ↗
34. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities10.1634/stemcells.2007-0054 ↗
35. Comprehensive analysis of chemotactic factors for bone marrow mesenchymal stem cells10.1089/scd.2006.0032 ↗
36. Tissue engineering and rotator cuff tendon healing10.1016/j.jse.2007.03.004 ↗
37. Genetically enhanced engineering of meniscus tissue using ex vivo delivery of transforming growth factor-beta 1 complementary deoxyribonucleic acid10.1089/ten.2006.0270 ↗
38. Collagen scaffolds for nonviral IGF-1 gene delivery in articular cartilage tissue engineering10.1038/sj.gt.3302918 ↗
39. Collagen-based matrices with axially oriented pores10.1002/jbm.a.31517 ↗
40. Fabricating tubular scaffolds with a radial pore size gradient by a spinning technique10.1016/j.biomaterials.2005.07.012 ↗
41. Influence of freezing rate on pore structure in freeze-dried collagen-GAG scaffolds10.1016/S0142-9612(03)00630-6 ↗
42. The generation of biomolecular patterns in highly porous collagen-GAG scaffolds using direct photolithography10.1016/j.biomaterials.2011.02.018 ↗
43. Cross-linking of dermal sheep collagen using a water-soluble carbodiimide10.1016/0142-9612(96)81413-X ↗
44. Mechanical characterization of collagen-glycosaminoglycan scaffolds10.1016/j.actbio.2006.12.009 ↗
45. Cellular materials as porous scaffolds for tissue engineering10.1016/S0079-6425(00)00018-9 ↗
46. Fluorometric assay of DNA in cartilage explants using Hoechst 3325810.1016/0003-2697(88)90532-5 ↗
47. Osteoblast activity on collagen-GAG scaffolds is affected by collagen and GAG concentrations10.1002/jbm.a.32207 ↗
48. Contraction of collagen-glycosaminoglycan matrices by peripheral nerve cells in vitro10.1016/S0142-9612(00)00345-8 ↗
49. Effect of aging on elastin functionality in human cerebral arteries10.1161/STROKEAHA.108.528091 ↗
50. A freeze-drying process for fabrication of polymeric bridges for peripheral nerve regeneration
51. Novel freeze-drying methods to produce a range of collagen-glycosaminoglycan scaffolds with tailored mean pore sizes10.1089/ten.tec.2009.0422 ↗
52. The effect of mean pore size on cell attachment, proliferation and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering10.1016/j.biomaterials.2009.09.063 ↗
53. ESB Research Award 1996. Biophysical stimuli on cells during tissue differentiation at implant interfaces10.1016/S0021-9290(96)00140-6 ↗
54. Effects of fluid flow on the in vitro degradation kinetics of biodegradable scaffolds for tissue engineering10.1016/S0142-9612(00)00112-5 ↗
55. Tendon cell contraction of collagen-GAG matrices in vitro: effect of cross-linking10.1016/S0142-9612(00)00051-X ↗
56. Mechanisms of gradient sensing and chemotaxis: conserved pathways, diverse regulation10.4161/cc.5.11.2770 ↗
57. Deterministic model of dermal wound invasion incorporating receptor-mediated signal transduction and spatial gradient sensing10.1529/biophysj.105.077610 ↗